- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Oculocutaneous Albinism (OCA) in Korea, Republic of
Total 16 results
-
Synthes GmbHCompletedClosed Proximal Tibial Fracture Schatzker I - VI | Closed Proximal Tibial Fracture AO-OTA 41 | Closed Proximal Tibial Fracture AO-OTA 42Korea, Republic of
-
Seoul National University HospitalCompleted
-
InSightecCompletedMedication-refractory Obsessive Compulsive Disorder (OCD)Korea, Republic of
-
Daewoong Pharmaceutical Co. LTD.UnknownMCA - Middle Cerebral Artery DissectionKorea, Republic of
-
Yonsei UniversityChong Kun Dang Pharmaceutical Corp.UnknownCoronary Artery Disease | Coronary Arteriosclerosis | Hydroxymethylglutaryl-CoA Reductase InhibitorsKorea, Republic of
-
Korea University Guro HospitalEnrolling by invitationDelirium, Dexmedetomidine, Postoperative PCAKorea, Republic of
-
Samsung Medical CenterCompletedAdherence, Medication | Percutaneous Coronary Intervention | Compliance, Medication | Platelet Aggregation Inhibitors | Hydroxymethylglutaryl-coa Reductase Inhibitors | Persistence, MedicationKorea, Republic of
-
Seung-Jung ParkCardioVascular Research Foundation, KoreaWithdrawnAngina Pectoris, Variant | Statins, HMG-CoAKorea, Republic of
-
Kiyuk Chang, MD,PhDRecruitingMyocardial Infarction | Statin Adverse Reaction | HMG-CoA Reductase Inhibitor ToxicityKorea, Republic of
-
AO Clinical Investigation and Publishing DocumentationDePuy SynthesActive, not recruitingTibial Fracture | Fracture of the Tibia Type AO/OTA 42United States, Hong Kong, Korea, Republic of, Switzerland, Singapore, Germany, South Africa, United Kingdom, Belgium
-
Ultragenyx Pharmaceutical IncCompletedLong-chain Fatty Acid Oxidation Disorders (LC-FAOD) | Very Long Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency | Trifunctional Protein (TFP) Deficiency | Carnitine Palmitoyltransferase (CPT II) Deficiency | Longchain 3-hydroxy-acyl-CoA Dehydrogenase (LCHAD) DeficiencyUnited States, United Kingdom
-
Ultragenyx Pharmaceutical IncCompletedCarnitine Palmitoyltransferase (CPT I or CPT II) Deficiency | Very Long Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency | Long-chain 3-hydroxy-acyl-CoA Dehydrogenase (LCHAD) Deficiency | Trifunctional Protein (TFP) Deficiency | Carnitine-acylcarnitine Translocase (CACT) DeficiencyUnited States, United Kingdom
-
Novartis PharmaceuticalsTerminatedPatient Diagnosed With OCD and Resistant to SSRI Treatment | Failed SSRI Over 12 Weeks at Appropriate DosesGermany, Switzerland, Bulgaria, United States, Czech Republic
-
AstraZenecaCompletedOsteoarthritis (OA) | Rheumatoid Arthritis (RA) | Ankylosing Spondylitis (AS)Mexico, Vietnam, Malaysia, Argentina, Philippines, Korea, Republic of, Venezuela, Colombia, Russian Federation, Thailand
-
PfizerCompletedNSCLC | SCCHN | Part 1 | MELANOMA | OVCA | SARCOMA | OTHER SOLID TUMORS | Part 1 and 2 | UROTHELIAL CARCINOMAUnited States, Korea, Republic of, Russian Federation, Poland, Malaysia, Bulgaria, Ukraine
-
AbbVieActive, not recruitingGiant Cell Arteritis (GCA)United States, Australia, Austria, Belgium, Canada, Czechia, Denmark, France, Germany, Greece, Hungary, Israel, Italy, Japan, Netherlands, New Zealand, Norway, Portugal, Romania, Russian Federation, Spain, Sweden, Switzerland, United...